July 22 (Reuters) - SeaStar Medical Holding Corp ICU.O:
SEASTAR MEDICAL REPORTS POSITIVE RESULTS FOR QUELIMMUNE THERAPY IN PEDIATRIC ACUTE KIDNEY INJURY (AKI) FROM THE FIRST 20 SAVE SURVEILLANCE REGISTRY PATIENTS
SEASTAR MEDICAL: SAVE SURVEILLANCE REGISTRY NEW DATA ON TRACK TO VALIDATE/POTENTIALLY EXCEED 50% REDUCTION IN LOSS OF LIFE VERSUS HISTORICAL DATA
Source text: ID:nGNX5MD78Q
Further company coverage: ICU.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.